Limits...
Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence.

Ghanaati H, Alavian SM, Jafarian A, Ebrahimi Daryani N, Nassiri-Toosi M, Jalali AH, Shakiba M - Iran J Radiol (2012)

Bottom Line: A variety of imaging modalities, such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear medicine are currently used in evaluating patients with HCC.Although the best option for the treatment of these cases is hepatic resection or transplantation, only 20% of HCCs are surgically treatable.In those patients who are not eligible for surgical treatment, interventional therapies such as transcatheter arterial chemoembolization (TACE), percutaneous ethanol injection (PEI), radio-frequency ablation (RFA), percutaneous microwave coagulation therapy (PMC), laser ablation or cryoablation, and acetic acid injection are indicated.

View Article: PubMed Central - PubMed

Affiliation: Department of Radiology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran ; Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Tehran, Iran.

ABSTRACT
The imaging of hepatocellular carcinoma (HCC) is challenging and plays a crucial role in the diagnosis and staging of the disease. A variety of imaging modalities, such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear medicine are currently used in evaluating patients with HCC. Although the best option for the treatment of these cases is hepatic resection or transplantation, only 20% of HCCs are surgically treatable. In those patients who are not eligible for surgical treatment, interventional therapies such as transcatheter arterial chemoembolization (TACE), percutaneous ethanol injection (PEI), radio-frequency ablation (RFA), percutaneous microwave coagulation therapy (PMC), laser ablation or cryoablation, and acetic acid injection are indicated. In this paper, we aimed to review the evidence regarding imaging modalities and therapeutic interventions of HCC.

No MeSH data available.


Related in: MedlinePlus

A, Dynamic CT scan, arterial phase shows hyperdense high vascular mass in the 4th segment of the liver; B, Dynamic CT scan, arterial phase, 5 min after RFA, shows a hypovascular area and complete vanishing of the enhancement.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3569547&req=5

fig754: A, Dynamic CT scan, arterial phase shows hyperdense high vascular mass in the 4th segment of the liver; B, Dynamic CT scan, arterial phase, 5 min after RFA, shows a hypovascular area and complete vanishing of the enhancement.

Mentions: Coagulative necrosis of the tumor using electrical heating around a probe generating electromagnetic radiation occurs after RFA (Figure 4) (57-59).


Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence.

Ghanaati H, Alavian SM, Jafarian A, Ebrahimi Daryani N, Nassiri-Toosi M, Jalali AH, Shakiba M - Iran J Radiol (2012)

A, Dynamic CT scan, arterial phase shows hyperdense high vascular mass in the 4th segment of the liver; B, Dynamic CT scan, arterial phase, 5 min after RFA, shows a hypovascular area and complete vanishing of the enhancement.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3569547&req=5

fig754: A, Dynamic CT scan, arterial phase shows hyperdense high vascular mass in the 4th segment of the liver; B, Dynamic CT scan, arterial phase, 5 min after RFA, shows a hypovascular area and complete vanishing of the enhancement.
Mentions: Coagulative necrosis of the tumor using electrical heating around a probe generating electromagnetic radiation occurs after RFA (Figure 4) (57-59).

Bottom Line: A variety of imaging modalities, such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear medicine are currently used in evaluating patients with HCC.Although the best option for the treatment of these cases is hepatic resection or transplantation, only 20% of HCCs are surgically treatable.In those patients who are not eligible for surgical treatment, interventional therapies such as transcatheter arterial chemoembolization (TACE), percutaneous ethanol injection (PEI), radio-frequency ablation (RFA), percutaneous microwave coagulation therapy (PMC), laser ablation or cryoablation, and acetic acid injection are indicated.

View Article: PubMed Central - PubMed

Affiliation: Department of Radiology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran ; Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Tehran, Iran.

ABSTRACT
The imaging of hepatocellular carcinoma (HCC) is challenging and plays a crucial role in the diagnosis and staging of the disease. A variety of imaging modalities, such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear medicine are currently used in evaluating patients with HCC. Although the best option for the treatment of these cases is hepatic resection or transplantation, only 20% of HCCs are surgically treatable. In those patients who are not eligible for surgical treatment, interventional therapies such as transcatheter arterial chemoembolization (TACE), percutaneous ethanol injection (PEI), radio-frequency ablation (RFA), percutaneous microwave coagulation therapy (PMC), laser ablation or cryoablation, and acetic acid injection are indicated. In this paper, we aimed to review the evidence regarding imaging modalities and therapeutic interventions of HCC.

No MeSH data available.


Related in: MedlinePlus